Human iris pigment epithelial cells suppress T-cell activation via direct cell contact

Experimental Eye Research

Volumn 89, Issue 3, 2009, Pages 358-364

  Hattori, Takaaki ^a   Kezuka, Takeshi ^a   Usui, Yoshihiko ^a   Okunuki, Yoko ^a   Takeuchi, Masaru ^a   Maruyama, Katsuhiko ^a   Haneda, Mai ^a   Shirato, Shiroaki ^a   Goto, Hiroshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

co stimulatory molecule; immune privilege; iris pigment epithelial cell; PD 1; PD L1; PD L2

Indexed keywords

CD3 ANTIBODY; GAMMA INTERFERON; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROGRAMMED DEATH LIGAND 1; PROGRAMMED DEATH LIGAND 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CELL CONTACT; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; EPITHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PIGMENT EPITHELIUM; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERON-GAMMA; IRIS; LYMPHOCYTE ACTIVATION; PIGMENT EPITHELIUM OF EYE; T-LYMPHOCYTES;

EID: 67651229244     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2009.04.004     Document Type: Article

References (46)

1. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., Yamazaki T., Azuma M., Iwai H., Khoury S.J., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198 (2003) 63-69
2. Carron J.A., Hiscott P., Hagan S., Sheridan C.M., Magee R., and Gallagher J.A. Cultured human retinal pigment epithelial cells differentially express thrombospondin-1, -2, -3, and -4. Int. J. Biochem. Cell Biol. 32 (2000) 1137-1142
3. D'Orazio T.J., Mayhew E., and Niederkorn J.Y. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1. J. Immunol. 166 (2001) 26-32
4. Dong H., Zhu G., Tamada K., and Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5 (1999) 1365-1369
5. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., and Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270 (1995) 1189-1192
6. Guleria I., Khosroshahi A., Ansari M.J., Habicht A., Azuma M., Yagita H., Noelle R.J., Coyle A., Mellor A.L., Khoury S.J., and Sayegh M.H. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J. Exp. Med. 202 (2005) 231-237
7. Hori J., Wang M., Miyashita M., Tanemoto K., Takahashi H., Takemori T., Okumura K., Yagita H., and Azuma M. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 177 (2006) 5928-5935
8. Ishida M., Iwai Y., Tanaka Y., Okazaki T., Freeman G.J., Minato N., and Honjo T. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol. Lett. 84 (2002) 57-62
9. Iwai Y., Terawaki S., Ikegawa M., Okazaki T., and Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 198 (2003) 39-50
10. Kaplan H.J., and Streilein J.W. Immune response to immunization via the anterior chamber of the eye. I.F. lymphocyte-induced immune deviation. J. Immunol. 118 (1977) 809-814
11. Kaplan H.J., and Streilein J.W. Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte-induced immune deviation. J. Immunol. 120 (1978) 689-693
12. Kim C.Y., Masli S., and Streilein J.W. Qa-1, a nonclassical MHC molecule with immunomodulatory functions, is ubiquitously expressed in the immune-privileged anterior chamber of the eye. Ocul. Immunol. Inflamm. 13 (2005) 271-277
13. Kinter A.L., Godbout E.J., McNally J.P., Sereti I., Roby G.A., O'Shea M.A., and Fauci A.S. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J. Immunol. 181 (2008) 6738-6746
14. Knisely T.L., Bleicher P.A., Vibbard C.A., and Granstein R.D. Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells. Curr. Eye Res. 10 (1991) 761-771
15. Liang S.C., Latchman Y.E., Buhlmann J.E., Tomczak M.F., Horwitz B.H., Freeman G.J., and Sharpe A.H. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 33 (2003) 2706-2716
16. Liversidge J., McKay D., Mullen G., and Forrester J.V. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 149 (1993) 315-330
17. Miyajima-Uchida H., Hayashi H., Beppu R., Kuroki M., Fukami M., Arakawa F., Tomita Y., Kuroki M., and Oshima K. Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 41 (2000) 561-567
18. Mo J.S., Anderson M.G., Gregory M., Smith R.S., Savinova O.V., Serreze D.V., Ksander B.R., Streilein J.W., and John S.W. By altering ocular immune privilege, bone marrow-derived cells pathogenically contribute to DBA/2J pigmentary glaucoma. J. Exp. Med. 197 (2003) 1335-1344
19. Namba K., Kitaichi N., Nishida T., and Taylor A.W. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J. Leukoc. Biol. 72 (2002) 946-952
20. Niederkorn J.Y., and Streilein J.W. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J. Immunol. 131 (1983) 2670-2674
21. -) thymocytes. Int. Immunol. 8 (1996) 773-780
22. Nishimura H., Minato N., Nakano T., and Honjo T. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10 (1998) 1563-1572
23. Okazaki T., and Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 27 (2006) 195-201
24. Petroff M.G., Chen L., Phillips T.A., Azzola D., Sedlmayr P., and Hunt J.S. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol. Reprod. 68 (2003) 1496-1504
25. Salama A.D., Chitnis T., Imitola J., Ansari M.J., Akiba H., Tushima F., Azuma M., Yagita H., Sayegh M.H., and Khoury S.J. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198 (2003) 71-78
26. Shen L., Jin Y., Freeman G.J., Sharpe A.H., and Dana M.R. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J. Immunol. 179 (2007) 3672-3679
27. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3 (2003) 879-889
28. Streilein J.W., and Bradley D. Analysis of immunosuppressive properties of iris and ciliary body cells and their secretory products. Invest. Ophthalmol. Vis. Sci. 32 (1991) 2700-2710
29. Streilein J.W., Niederkorn J.Y., and Shadduck J.A. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J. Exp. Med. 152 (1980) 1121-1125
30. Subudhi S.K., Zhou P., Yerian L.M., Chin R.K., Lo J.C., Anders R.A., Sun Y., Chen L., Wang Y., Alegre M.L., and Fu Y.X. Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J. Clin. Invest. 113 (2004) 694-700
31. Sugita S., Ng T.F., Schwartzkopff J., and Streilein J.W. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J. Immunol. 172 (2004) 4184-4194
32. Sugita S., Keino H., Futagami Y., Takase H., Mochizuki M., Stein-Streilein J., and Streilein J.W. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest. Ophthalmol. Vis. Sci. 47 (2006) 5376-5384
33. Sugita S., Usui Y., Horie S., Futagami Y., Yamada Y., Ma J., Kezuka T., Hamada H., Usui T., Mochizuki M., and Yamagami S. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism. Invest. Ophthalmol. Vis. Sci. 50 (2009) 263-272
34. Sugita S., and Streilein J.W. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 198 (2003) 161-171
35. Tanihara H., Yoshida M., Matsumoto M., and Yoshimura N. Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 34 (1993) 413-419
36. Taylor A.W., Streilein J.W., and Cousins S.W. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr. Eye Res. 11 (1992) 1199-1206
37. Taylor A.W., Streilein J.W., and Cousins S.W. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J. Immunol. 153 (1994) 1080-1086
38. Taylor A.W., Yee D.G., and Streilein J.W. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1372-1378
39. Tseng S.Y., Otsuji M., Gorski K., Huang X., Slansky J.E., Pai S.I., Shalabi A., Shin T., Pardoll D.M., and Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193 (2001) 839-846
40. Usui Y., Okunuki Y., Hattori T., Kezuka T., Keino H., Ebihara N., Sugita S., Usui M., Goto H., and Takeuchi M. Functional expression of B7H1 on retinal pigment epithelial cells. Exp. Eye Res. 86 (2008) 52-59
41. Watson M.P., George A.J., and Larkin D.F. Differential effects of costimulatory pathway modulation on corneal allograft survival. Invest. Ophthalmol. Vis. Sci. 47 (2006) 3417-3422
42. Wiendl H., Hohlfeld R., and Kieseier B.C. Muscle-derived positive and negative regulators of the immune response. Curr. Opin. Rheumatol. 17 (2005) 714-719
43. Wilbanks G.A., Mammolenti M., and Streilein J.W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur. J. Immunol. 22 (1992) 165-173
44. Yamazaki T., Akiba H., Iwai H., Matsuda H., Aoki M., Tanno Y., Shin T., Tsuchiya H., Pardoll D.M., Okumura K., et al. Expression of programmed death 1 ligands by murine T cells and APC. J. Immunol. 169 (2002) 5538-5545
45. Yoshida M., Kezuka T., and Streilein J.W. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Invest. Ophthalmol. Vis. Sci. 41 (2000) 3862-3870
46. Yoshida M., Takeuchi M., and Streilein J.W. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest Ophthalmol. Vis. Sci. 41 (2000) 811-821